Updated:
Livongo Health
Livongo Health — digital chronic-disease management platform, acquired by Teladoc in 2020.
Livongo Health
Livongo Health was founded in 2014 to provide remote monitoring and personalized coaching for people with chronic conditions, beginning with diabetes. The company raised over $400 million in venture funding from investors including General Catalyst, Kleiner Perkins, and Sequoia Capital before its 2019 IPO.
General information
Firm type
other
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Mountain View
Corporate office
Mountain View, CA, United States
Principals
Glen Tullman
CEO (2014–2020)
Jennifer Schneider
CEO (2020–2021)
Sector focus
Frequently asked questions
Who ran investment decisions at Livongo?
Glen Tullman served as CEO from founding through the IPO and merger; Jennifer Schneider succeeded him briefly in 2020. The board included healthcare investors from General Catalyst and Sequoia.
What was Livongo's business model?
Livongo charged employers and health plans a per-member per-month fee for its connected devices, coaching, and digital platform. It focused on diabetes initially, then expanded to hypertension and weight management.
Is Livongo still operating as a standalone entity?
No. Livongo merged with Teladoc Health in October 2020 and now operates as part of Teladoc's chronic care segment.
What investment stages did Livongo target?
Livongo raised venture rounds from Series A through IPO; its largest known backers were General Catalyst (lead Series D) and Sequoia Capital.
Which sectors did Livongo explicitly focus on?
Livongo focused exclusively on digital health for chronic conditions — diabetes, hypertension, weight management — not on general wellness or acute care.
How was Livongo related to Teladoc?
Livongo merged with Teladoc in 2020, creating a combined virtual-care and chronic-disease management platform. Teladoc retained the Livongo brand for its chronic care products.
Where did Livongo's underlying wealth come from?
The company was venture-funded, not derived from family wealth; its largest shareholders were institutional investors and the founding team.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: